Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories
-
'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor
-
Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings
-
SentinelOne Inc (S) PT Raised to $26 at Cantor Fitzgerald Following Strong Q2 Checks
-
Okta, Inc (OKTA) PT Raised to $170 at Cantor Fitzgerald Ahead of Q2 Results
-
Cantor Fitzgerald Starts Milestone Pharmaceuticals (MIST) at Overweight
-
Form 13F-HR/A CANTOR FITZGERALD, L. For: Jun 30
-
CrowdStrike (CRWD) PT Adjusted $250 at Cantor Fitzgerald Post Stock Split
-
Form N-23C3A CANTOR FITZGERALD INFRAS For: Aug 19
-
Cantor Fitzgerald launches prediction market trading for institutions
-
Cantor Commences Institutional Block Trading in Prediction Markets
-
Cypherpunk Technologies (CYPH) PT Raised to $1.60 at Cantor Fitzgerald as Mining Launch Announced
-
Nebius Group (NBIS) Reiterated at Overweight by Cantor Fitzgerald Despite Data Center Opposition
-
Keel Infrastructure (KEEL) Reiterated at Overweight by Cantor Fitzgerald Amid Opposition
-
Centuri Holdings Inc (CTRI) PT Raised to $36 at Cantor Fitzgerald on Strong Revenue Visbility
-
Zscaler (ZS) Reiterated at Overweight by Cantor Fitzgerald: Bullish on Red Canary Synergies
-
Cantor Fitzgerald Starts Agomab Therapeutics (AGMB) at Overweight
-
Palo Alto Networks (PANW) PT Raised to $425 at Cantor Fitzgerald
-
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Quince Therapeutics Inc. (QNCX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Aon Corp (AON) Amid CFO Transition
-
Amgen (AMGN) PT Raised to $400 at Cantor Fitzgerald on Higher Sales Estimates
-
Duos Technologies Group (DUOT) PT Raised to $27 at Cantor Fitzgerald on 'Extremely Attractive' Risk/Reward
-
Carepoint Announces Partnership with New Heritage Capital
-
Enovix Corporation (ENVX) PT Lowered to $10 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades EyePoint Inc. (EYPT) to Neutral
-
Terreno Realty Corp (TRNO) PT Raised to $77 at Cantor Fitzgerald on Leasing Optimism
-
MiMedx Group (MDXG) Reiterated at Overweight by Cantor Fitzgerald: Wound Care Market Stable
-
NeuroPace (NPCE) Reiterated at Overweight by Cantor Fitzgerald on Commercial Momentum
-
Analog Devices (ADI) Reiterated at Overweight by Cantor Fitzgerald: Beat and Raise Expected
-
Agios Pharma (AGIO) Reiterated at Overweight by Cantor Fitzgerald on Thalassemia Opportunity
-
CVRx Inc (CVRX) PT Lowered to $5 at Cantor Fitzgerald on Q2 Update Pressures
-
Nyxoah SA (NYXH) PT Lowered to $6 at Cantor Fitzgerald to Reflect Current Trading Levels
-
Silence Therapeutics closes $201M public offering of ADSs
-
Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
-
Form 424B3 Cantor Fitzgerald Income
-
Thunder Bridge Capital Partners V, Ltd. Announces Closing of $300.15 Million Initial Public Offering, Including Full Exercise of Over-Allotment Option
-
A1R water Debuts as Publicly Traded Company to Build Leading CPG Brand in Atmospheric Water
-
Form 13F-NT CANTOR FITZGERALD & CO. For: Jun 30
-
Form 13F-NT Cantor Fitzgerald Europe For: Jun 30
-
Form 13F-HR CANTOR FITZGERALD, L. For: Jun 30
-
Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)
-
Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
-
Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)
-
Powell Industries (POWL) PT Lowered to $235 at Cantor Fitzgerald
-
SoundThinking (SSTI) PT Lowered to $8 at Cantor Fitzgerald
-
Cantor Fitzgerald Upgrades Capricor Therapeutics (CAPR) to Overweight
-
Form 10-Q Cantor Fitzgerald Income For: Jun 30
-
Form N-PX CANTOR FITZGERALD INVEST For: Jun 30
-
CapsoVision sets up $100M at-the-market stock offering via Cantor
-
ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights

